Welcome!

News Feed Item

OBN's 2013 Annual Awards Dinner Celebrates UK Bioscience Success Stories

OXFORD, England, October 1, 2013 /PRNewswire/ --


 http://www.obn.org.uk/obn_/menu.php?p=rss&rn=rssfeed&prechk_news=1

OBN's Annual Awards Dinner this evening celebrated the achievements and major success stories in biotech, medtech and diagnostics over the past year at a black tie event at The Ashmolean Museum, Oxford. The Awards seek to highlight the many achievements of the UK's bioscience sector in raising funds, executing deals and supporting innovation. OBN's Awards recognize these achievements, taking into account its significance for the stage of development of a nominated life sciences company, as well as the scale of the achievement.

The 2013 award winners were:

Circassia, Best New Biotech Development Programme

Award Presented by J A Kemp

Circassia's ToleroMune® cat allergy treatment maintained symptom improvement two years after the start of Short-Course Therapy in a phase II clinical trial, while their HDM-SPIRE treatment for house dust mite allergy also achieved long-term symptom reduction.

OrganOx, Best New Medtech Development Programme

Award Presented by Citigate

OrganOx has developed metra™ - a system which enables the repair, preservation and objective viability assessment of livers prior to transplantation. It has already been used successfully for several transplantation procedures in 2013.

Autifony Therapeutics, Best Emerging Biotech

Award Presented by James Cowper

Autifony is developing new drugs to treat hearing disorders by targeting specific ion channels which regulate neuronal activity within the auditory system. A top up series A round of £5.5m in June 2013 brings funds raised to £15.5m, plus a £2.75m collaboration also announced in 2013.

Parsortix, Best Emerging Medtech

Award Presented by Team Consulting

Angle plc spin-out Parsortix has separation technology which captures very rare circulating tumour cells (CTCs) in cancer patient blood. They have launched a research market product but also aim to secure CE Mark approval for the clinical market in 2013, with FDA approval sought during 2014.

Karus Therapeutics, Best Biotech Fundraiser

Award Presented by Akesios Associates

Karus raised £5m as the first tranche of a Series B investment in September 2012 from top tier investors SV Life Sciences (UK and International), New Leaf Venture Partners (US), Novo A/S (Denmark), IP Group (UK), Esperante Ventures (Netherlands) and a number of Angel investors. This award recognizes the progression the company has made in securing this fundraising from this syndicate.

Glide Pharma, Best Medtech Fundraiser

Award Presented by Milton Park

Glide Pharma raised £14m in Feb 2013 from Invesco Perpetual and existing investors.  This will enable the scale-up of manufacturing for its Glide SDI injector system (both drug and device).  Glide won an additional £2.3m of project funding from TSB in the form of a Biomedical Catalyst competition award.

Immunocore,  Best Biotech Dealmaker

Award Presented by E&Y

Immunocore secured a £142m deal with GSK (July 2013) for ImmTACs to treat cancer and viral disease and a research collaboration and licensing agreement with Genentech (June 2013), valued at up to £300m. The deals come with potential fees and milestone payments which could be worth hundreds of millions according to industry commentators.

Oxford Gene Technology,  Best Medtech Dealmaker

Award Presented by Wilmerhale

Oxford Gene Technology collaboratively developed  a panel of 58 cancer-associated genes for diagnostic purposes with Birmingham and Salisbury NHS Regional Genetics Laboratories backed by £1.16m in funding from the TSB (May 2013).

Technology Strategy Board,  Highest Impact Investor

Award Presented by OBN

This award is made to the TSB in recognition of the impact of the Biomedical Catalyst, making investments of up to £122m over its first 18 months, including up to 112 awards to small-to-medium sized companies in the sector.

Shire,  Best Pharma BD&L Team

Award Presented by World Courier

Shire strengthened its rare disease and opthalmology portfolio with a number of significant acquisitions including Premacure AB, Lotus Tissue Repair, and SARCode Bioscience, and entered into a number of new co-development deals.

Dr Jon Rees, OBN's CEO, said: "This year's awards highlight the vibrancy and variety of the broader life sciences sector in the UK and, despite tough financing conditions, the progress companies have been able to make and the tangible successes delivered. As OBN expands its sphere of influence across the UK, we were delighted to welcome a larger number of entrepreneurs from across the UK to the Awards Dinner than any previous year."

**Photographs of the Awards are available on request**


About OBN


OBN is the membership organisation supporting and bringing together the UK's emerging life science companies, corporate partners and investors within the Golden Triangle biocluster (formed by the cities of Oxford, Cambridge and London) and beyond, providing networking, partnering, group purchasing, advocacy and cluster consultancy.

Through our delivery of Europe's third largest annual biopartnering and investment conference 'BioTrinity', which is expected to attract 1000+ delegates from 30 countries, OBN will generate more R&D-company-to-investor interactions than anyone else in Europe.

For further information on OBN and its activities, please visit: http://www.obn.org.uk or to find out more about BioTrinity, please visit http://www.biotrinity.com

Contacts

OBN
David Boal, Director of Business Development
Tel: +44(0)845-5049-743
[email protected]


Citigate Dewe Rogerson
Janine Hagan
Tel: +44(0)20-7638-9571
[email protected]

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Internet-of-Things discussions can end up either going down the consumer gadget rabbit hole or focused on the sort of data logging that industrial manufacturers have been doing forever. However, in fact, companies today are already using IoT data both to optimize their operational technology and to improve the experience of customer interactions in novel ways. In his session at @ThingsExpo, Gordon Haff, Red Hat Technology Evangelist, shared examples from a wide range of industries – including en...
In IT, we sometimes coin terms for things before we know exactly what they are and how they’ll be used. The resulting terms may capture a common set of aspirations and goals – as “cloud” did broadly for on-demand, self-service, and flexible computing. But such a term can also lump together diverse and even competing practices, technologies, and priorities to the point where important distinctions are glossed over and lost.
In his session at @DevOpsSummit at 20th Cloud Expo, Kelly Looney, director of DevOps consulting for Skytap, showed how an incremental approach to introducing containers into complex, distributed applications results in modernization with less risk and more reward. He also shared the story of how Skytap used Docker to get out of the business of managing infrastructure, and into the business of delivering innovation and business value. Attendees learned how up-front planning allows for a clean sep...
Detecting internal user threats in the Big Data eco-system is challenging and cumbersome. Many organizations monitor internal usage of the Big Data eco-system using a set of alerts. This is not a scalable process given the increase in the number of alerts with the accelerating growth in data volume and user base. Organizations are increasingly leveraging machine learning to monitor only those data elements that are sensitive and critical, autonomously establish monitoring policies, and to detect...
Most companies are adopting or evaluating container technology - Docker in particular - to speed up application deployment, drive down cost, ease management and make application delivery more flexible overall. As with most new architectures, this dream takes a lot of work to become a reality. Even when you do get your application componentized enough and packaged properly, there are still challenges for DevOps teams to making the shift to continuous delivery and achieving that reduction in cost ...
Enterprise architects are increasingly adopting multi-cloud strategies as they seek to utilize existing data center assets, leverage the advantages of cloud computing and avoid cloud vendor lock-in. This requires a globally aware traffic management strategy that can monitor infrastructure health across data centers and end-user experience globally, while responding to control changes and system specification at the speed of today’s DevOps teams. In his session at 20th Cloud Expo, Josh Gray, Chie...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. Jack Norris reviews best practices to show how companies develop, deploy, and dynamically update these applications and how this data-first...
Intelligent Automation is now one of the key business imperatives for CIOs and CISOs impacting all areas of business today. In his session at 21st Cloud Expo, Brian Boeggeman, VP Alliances & Partnerships at Ayehu, will talk about how business value is created and delivered through intelligent automation to today’s enterprises. The open ecosystem platform approach toward Intelligent Automation that Ayehu delivers to the market is core to enabling the creation of the self-driving enterprise.
"At the keynote this morning we spoke about the value proposition of Nutanix, of having a DevOps culture and a mindset, and the business outcomes of achieving agility and scale, which everybody here is trying to accomplish," noted Mark Lavi, DevOps Solution Architect at Nutanix, in this SYS-CON.tv interview at @DevOpsSummit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We're here to tell the world about our cloud-scale infrastructure that we have at Juniper combined with the world-class security that we put into the cloud," explained Lisa Guess, VP of Systems Engineering at Juniper Networks, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Historically, some banking activities such as trading have been relying heavily on analytics and cutting edge algorithmic tools. The coming of age of powerful data analytics solutions combined with the development of intelligent algorithms have created new opportunities for financial institutions. In his session at 20th Cloud Expo, Sebastien Meunier, Head of Digital for North America at Chappuis Halder & Co., discussed how these tools can be leveraged to develop a lasting competitive advantage ...
WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web communications world. The 6th WebRTC Summit continues our tradition of delivering the latest and greatest presentations within the world of WebRTC. Topics include voice calling, video chat, P2P file sharing, and use cases that have already leveraged the power and convenience of WebRTC.
"We're a cybersecurity firm that specializes in engineering security solutions both at the software and hardware level. Security cannot be an after-the-fact afterthought, which is what it's become," stated Richard Blech, Chief Executive Officer at Secure Channels, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
In his session at 20th Cloud Expo, Mike Johnston, an infrastructure engineer at Supergiant.io, discussed how to use Kubernetes to set up a SaaS infrastructure for your business. Mike Johnston is an infrastructure engineer at Supergiant.io with over 12 years of experience designing, deploying, and maintaining server and workstation infrastructure at all scales. He has experience with brick and mortar data centers as well as cloud providers like Digital Ocean, Amazon Web Services, and Rackspace. H...
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.